ID: ALA5277759

Max Phase: Preclinical

Molecular Formula: C23H27N7O

Molecular Weight: 417.52

Associated Items:

Representations

Canonical SMILES:  Cc1nn(C)c2ccc(N(Cc3cccnc3)C(=O)NCCCn3cncc3C)cc12

Standard InChI:  InChI=1S/C23H27N7O/c1-17-13-25-16-29(17)11-5-10-26-23(31)30(15-19-6-4-9-24-14-19)20-7-8-22-21(12-20)18(2)27-28(22)3/h4,6-9,12-14,16H,5,10-11,15H2,1-3H3,(H,26,31)

Standard InChI Key:  VOABSUIATFUZCK-UHFFFAOYSA-N

Associated Targets(Human)

Glutaminyl-peptide cyclotransferase 1121 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HERG 29587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

HT-22 3261 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 417.52Molecular Weight (Monoisotopic): 417.2277AlogP: 3.59#Rotatable Bonds: 7
Polar Surface Area: 80.87Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.33CX LogP: 1.22CX LogD: 1.03
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.47Np Likeness Score: -1.99

References

1. Van Manh N, Hoang VH, Ngo VTH, Kang S, Jeong JJ, Ha HJ, Kim H, Kim YH, Ann J, Lee J..  (2022)  Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents.,  244  [PMID:36265279] [10.1016/j.ejmech.2022.114837]

Source